Literature DB >> 582078

Reemergence of thyroidectomy as treatment for Graves' disease.

P Klementschitsch, K L Shen, E L Kaplan.   

Abstract

Hyperthyroidism of Graves' disease may be treated very effectively by antithyroid pills, such as PTU and Tapazole, by radioactive iodine therapy, and by subtotal thyroidectomy. Each form of therapy has advantages and disadvantages, and thus treatment should be individualized. While therapy with radioactive iodine would appear to be ideal since it does not require an operation and is less expensive than surgical management, it suffers from a high rate of progressive hypothyroidism and from the fact that the time until a euthyroid state is obtained is often prolonged. In addition, the long-term carcinogenic risk of the therapy for thyroid neoplasia has never been completely defined since the data most often quoted have a mean follow-up time of only eight years. Furthermore, new "low-dose" radioiodine regimens may be more dangerous in this regard. Subtotal thyroidectomy, while not totally without complications, remains a rapid, safe, and effective treatment for Graves' disease. The careful use of propranolol has facilitated the preparation of some patients and has lessened the risk of operation. Thyroidectomy should remain the treatment of choice for young adults with this disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 582078     DOI: 10.1016/s0039-6109(16)41731-7

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

Review 1.  Review of general surgery 1979.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

2.  Could total thyroidectomy become the standard treatment for Graves' disease?

Authors:  Ayhan Koyuncu; Cengiz Aydin; Omer Topçu; Oruç Numan Gökçe; Sahande Elagöz; Hatice Sebila Dökmetaş
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

3.  Total thyroidectomy as a method of choice in the treatment of Graves' disease - analysis of 1432 patients.

Authors:  Toplica Bojic; Ivan Paunovic; Aleksandar Diklic; Vladan Zivaljevic; Goran Zoric; Nevena Kalezic; Vera Sabljak; Nikola Slijepcevic; Katarina Tausanovic; Nebojsa Djordjevic; Dragana Budjevac; Lidija Djordjevic; Aleksandar Karanikolic
Journal:  BMC Surg       Date:  2015-04-09       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.